Chosa Oncology AB
Share:
Subscribe:
news.cision.com
/
Chosa Oncology AB
/
CHOSA Oncology AB publishes results from clinical phase 2 trial of liposomal formulation in breast cancer, using predictive marker for cisplatin
/
3780137_0.png
3780137_0.png
Sat, Jun 03, 2023 15:00 CET
Low resolution
Medium resolution
Original resolution
Subscribe
